@article{muguet-chanoit_olby_lim_gallagher_niman_dillard_campbell_early_mariani_muñana_et al._2011, title={The Cutaneous Trunci Muscle Reflex: A Predictor of Recovery in Dogs with Acute Thoracolumbar Myelopathies Caused by Intervertebral Disc Extrusions}, volume={41}, ISSN={0161-3499}, url={http://dx.doi.org/10.1111/j.1532-950X.2011.00921.x}, DOI={10.1111/j.1532-950x.2011.00921.x}, abstractNote={Objective To determine whether changes in the cutaneous trunci muscle (CTM) reflex are an early predictor of outcome in dogs with severe acute thoracolumbar intervertebral disc extrusion (IVDE). Study Design Multicenter prospective cohort study. Animals Dogs (n = 36) with acute IVDE causing paraplegia, loss of nociception in pelvic limbs and tail, and an abnormal CTM reflex postoperatively. Methods The caudal border of the CTM reflex was established 24 hours after surgery and at discharge, and was reported as moving cranially, caudally, or staying static. Dogs were re-evaluated at 12–20 weeks and at 7–36 months postoperatively. Outcome was classified as improved or unimproved, successful or unsuccessful, and ascending myelomalacia or not, and compared with early movement of the CTM reflex by construction of contingency tables and performing a Fisher's exact test. Results By discharge (mean, 4.7 days; SD = 2.10), CTM reflex progression was caudal in 19 dogs, static in 11, and cranial in 6. Five of 6 dogs with cranial movement developed ascending myelomalacia (P < .0001). Seventeen of 19 dogs with caudal movement showed an improvement by 12–20 weeks (P = .0046) and none developed ascending myelomalacia (P = .0013). Conclusions Postoperative changes of the caudal border of the CTM reflex are an early indicator of outcome in dogs with severe acute IVDE. Cranial movement of the CTM reflex is significantly associated with the development of ascending myelomalacia. Caudal movement is significantly associated with improvement, but not associated with a long-term successful outcome.}, number={2}, journal={Veterinary Surgery}, publisher={Wiley}, author={Muguet-Chanoit, Audrey C. and Olby, Natasha J. and Lim, Ji-Hey and Gallagher, Ryan and Niman, Zachary and Dillard, Stacy and Campbell, James and Early, Peter and Mariani, Christopher L. and Muñana, Karen R. and et al.}, year={2011}, month={Dec}, pages={200–206} }
 @article{muguet-chanoit_olby_babb_lim_gallagher_niman_dillard_campbell_2011, title={The sensory field and repeatability of the cutaneous trunci muscle reflex of the dog}, volume={40}, number={7}, journal={Veterinary Surgery}, author={Muguet-Chanoit, A. C. and Olby, N. J. and Babb, K. M. and Lim, J. H. and Gallagher, R. and Niman, Z. and Dillard, S. and Campbell, J.}, year={2011}, pages={781–785} }
 @article{flammer_nettifee osborne_webb_foster_dillard_davis_2008, title={Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh)}, volume={69}, ISSN={0002-9645}, url={http://dx.doi.org/10.2460/ajvr.69.1.114}, DOI={10.2460/ajvr.69.1.114}, abstractNote={Abstract Objective —To determine the pharmacokinetics and safety of orally administered voriconazole in African grey parrots. Animals —20 clinically normal Timneh African grey parrots ( Psittacus erithacus timneh ). Procedures —In single-dose trials, 12 parrots were each administered 6, 12, and 18 mg of voriconazole/kg orally and plasma concentrations of voriconazole were determined via high-pressure liquid chromatography. In a multiple-dose trial, voriconazole (18 mg/kg) was administered orally to 6 birds every 12 hours for 9 days; a control group (2 birds) received tap water. Treatment effects were assessed via observation, clinicopathologic analyses (3 assessments), and measurement of trough plasma voriconazole concentrations (2 assessments). Results —Voriconazole's elimination half-life was short (1.1 to 1.6 hours). Higher doses resulted in disproportional increases in the maximum plasma voriconazole concentration and area under the curve. Trough plasma voriconazole concentrations achieved in the multiple-dose trial were lower than those achieved after administration of single doses. Polyuria (the only adverse treatment effect) developed in treated and control birds but was more severe in the treatment group. Conclusions and Clinical Relevance —In African grey parrots, voriconazole has dose-dependent pharmacokinetics and may induce its own metabolism. Oral administration of 12 to 18 mg of voriconazole/kg twice daily is a rational starting dose for treatment of African grey parrots infected with Aspergillus or other fungal organisms that have a minimal inhibitory concentration for voriconazole ≤ 0.4 μg/mL. Higher doses may be needed to maintain plasma voriconazole concentrations during long-term treatment. Safety and efficacy of various voriconazole treatment regimens in this species require investigation.}, number={1}, journal={American Journal of Veterinary Research}, publisher={American Veterinary Medical Association (AVMA)}, author={Flammer, Keven and Nettifee Osborne, Julie A. and Webb, Donna J. and Foster, Laura E. and Dillard, Stacy L. and Davis, Jennifer L.}, year={2008}, month={Jan}, pages={114–121} }